Login / Signup
Didi Bury
ORCID
Publication Activity (10 Years)
Years Active: 2021-2023
Publications (10 Years): 3
Top Topics
Pseudomonas Aeruginosa
Cell Wall
Childhood Cancer
Chronic Pain
Top Venues
The Journal of antimicrobial chemotherapy
Clinical pharmacokinetics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Didi Bury
,
Tom F W Wolfs
,
Rob Ter Heine
,
Eline W Muilwijk
,
Kim C M van der Elst
,
Wim J E Tissing
,
Roger J M Brüggemann
Pharmacokinetic investigations of isavuconazole in paediatric cancer patients show reduced exposure of isavuconazole after opening capsules for administration via a nasogastric tube.
The Journal of antimicrobial chemotherapy
(2023)
Didi Bury
,
Tom F W Wolfs
,
Rob Ter Heine
,
Eline W Muilwijk
,
Wim J E Tissing
,
Roger J M Brüggemann
Pharmacokinetic evaluation of twice-a-week micafungin for prophylaxis of invasive fungal disease in children with acute lymphoblastic leukaemia: a prospective observational cohort study.
The Journal of antimicrobial chemotherapy
77 (3) (2022)
Didi Bury
,
Wim J E Tissing
,
Eline W Muilwijk
,
Tom F W Wolfs
,
Roger J M Brüggemann
Clinical Pharmacokinetics of Triazoles in Pediatric Patients.
Clinical pharmacokinetics
60 (9) (2021)